Comparing Baseline and Day-1 Diffusion MRI Using Multimodal Deep Embeddings for Stroke Outcome Prediction

summary

Video file (mp4)

The gist

The gist: J1 multimodal models achieved the highest predictive performance (AUC = 0.923 ± 0.085), outperforming J0-based configurations (AUC ≤ 0.86).

In short

The study compared baseline (J0) and 24-hour post-stroke (J1) diffusion MRI to predict three-month functional outcomes after acute ischemic stroke. J1 imaging showed superior predictive power, achieving an AUC of 0.923, significantly better than J0 configurations. Integrating deep MRI embeddings with clinical and lesion volume features created a robust model that is both highly accurate and interpretable.

Key concepts

Baseline vs. Day-1 Diffusion MRI (J0 vs J1)
This compares diffusion MRI scans taken at the time of stroke (baseline, J0) with those taken 24 hours later (J1). The research tested whether the change in diffusion patterns within this first day provides a better signal for predicting long-term patient recovery than just looking at the initial scan.
3D ResNet-50 Embeddings
ResNet-50 is a deep neural network used to analyze complex 3D MRI data. It converts the detailed diffusion MRI scans into compact, meaningful numerical representations called embeddings. These embeddings capture the essential structural and tissue characteristics of the brain in a way that machine learning models can easily use.
Multimodal Fusion and PCA
This process combines different types of data—MRI features, clinical variables, and lesion volumes—into one comprehensive set. Principal Component Analysis (PCA) is then used to reduce the complexity of this combined data down to a manageable number of key components while retaining most of the important predictive information.

Terminology used across episodes

This episode discusses

The paper

Comparing Baseline and Day-1 Diffusion MRI Using Multimodal Deep Embeddings for Stroke Outcome Prediction · Read on arXiv

Sina Raeisadigh, Myles Joshua Toledo Tan, Henning Muller, Abderrahmane Hedjoudje

Department of Computer Science, University of Geneva, Switzerland · Department of Electrical & Computer Engineering, University of Florida, FL, USA · Service of Medical Informatics, University Hospital of Geneva, Switzerland · Department of Imaging and Medical Informatics, University of Geneva

This study compares baseline (J0) and 24-hour (J1) diffusion magnetic resonance imaging (MRI) for predicting three-month functional outcomes after acute ischemic stroke (AIS). Seventy-four AIS patients with paired apparent diffusion coefficient (ADC) scans and clinical data were analyzed. Three-dimensional ResNet-50 embeddings were fused with structured clinical variables, reduced via principal component analysis (<=12 components), and classified using linear support vector machines with eight-fold stratified group cross-validation. J1 multimodal models achieved the highest predictive performance (AUC = 0.923 +/- 0.085), outperforming J0-based configurations (AUC <= 0.86). Incorporating lesion-volume features further improved model stability and interpretability. These findings demonstrate that early post-treatment diffusion MRI provides superior prognostic value to pre-treatment imaging and that combining MRI, clinical, and lesion-volume features produces a robust and interpretable framework for predicting three-month functional outcomes in AIS patients.

DOI: 10.1109/ISBI61618.2026.11515670

Transcript

Introduction to the show: ident: AI Radio. Generated commentary on the latest Artificial Intelligence papers.

Tom: We're looking at the paper: "Comparing Baseline and Day-1 Diffusion MRI Using Multimodal Deep Embeddings for Stroke Outcome Prediction".

Jane: Here's the gist of the paper. The gist: J1 multimodal models achieved the highest predictive performance (AUC = 0.923 ± 0.085), outperforming J0-based configurations (AUC ≤ 0.86).

Tom: Study Objective This study compares baseline (J0) and 24-hour (J1) diffusion magnetic resonance imaging for predicting three-month functional outcomes after acute ischemic stroke (AIS) The goal was to determine if early posttreatment diffusion MRI provides superior prognostic value to pre-treatment imaging.

Jane: The researchers hypothesized that post-treatment (J1) imaging, combined with clinical and lesion-volume features, can improve predictive performance and interpretability.

Tom: The study analyzed seventy-four AIS patients with paired apparent diffusion coefficient (ADC) scans and clinical data.

Paper summary: Tom: What this means for us on the air is that we're seeing a clear signal that the change in diffusion within twenty-four hours after stroke is a much stronger predictor of recovery than just looking at the initial scan.

Jane: It’s interesting because they explicitly compared J0 and J1 MRI models, showing that J1 outperformed J0 across all metrics, including AUC zero point seven one four plus or minus zero point one zero five versus zero point five four zero plus or minus zero point two six three > <ref:2512.02088#pg3,J0 and J1 MRI models>

Lu: They are using the comparison of baseline versus Day-one diffusion MRI to show that the changes captured at J1 provide a stronger prognostic signal than the initial baseline scan, which is what they found in Table one > <ref:2512.02088#pg1>

Meng: It’s good to see how they built this up, integrating deep volumetric and clinical features first, and then seeing how adding those lesion-volume metrics further improves things >

Lalam: Integrating imaging features with clinical data brought the multimodal model up to an AUC of zero point eight nine four plus or minus zero point one zero six, which shows that combining the modalities is pretty valuable > <ref:2512.02088#pg3>

Conclusion: Tom: So looking at the title, Comparing Baseline and Day-one Diffusion MRI Using Multimodal Deep Embeddings for Stroke Outcome Prediction, it really highlights that the method isn't just about comparing two scans; it’s about using deep learning embeddings to build a robust prediction framework <ref:2512.02088#pg1,Comparing Baseline and Day-1 Diffusion MRI Using Multimodal Deep Embeddings for>.

Jane: And what this implies is that for stroke prognosis, we should be looking at early post-treatment diffusion MRI as a key piece of information rather than just the baseline scan >

Lu: The framework they proposed uses PCA to reduce the three dimensional ResNet-fifty embeddings down to twelve components, which makes it more stable and interpretable by ensuring >ninety-five percent variance is retained in those components >

Meng: From a deployment standpoint, having a model that can be interpreted through those principal components gives us some transparency on why the AI made a certain prediction >

Lalam: The overall conclusion is that this PCA support vector machine framework offers a clinically translatable foundation for personalized stroke prognosis by integrating quantitative diffusion MRI with structured clinical data >

More episodes

← Home